Among them, high expression levels of SMARCC1, SRSF10, PRPF38A, JARID2, GNAI3, miR-301a-3p, miR-106b-5p, miRNA-130b-3p, miR-423-3p and LINC01296 and low expression levels of ARF3 and PRKCB were associated with shorter overall survival in sarcomas (Fig. 6). Here, SRSF10 is linked to sarcoma.